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Heart Rhythm Disorders
The Relation Between Hospital
Procedure Volume and Complications
of Cardioverter-Defibrillator Implantation From
the Implantable Cardioverter-Defibrillator Registry
James V. Freeman, MD, MPH,* Yongfei Wang, MS,† Jeptha P. Curtis, MD,†
Paul A. Heidenreich, MD, MS,‡ Mark A. Hlatky, MD*
Stanford and Palo Alto, California; and New Haven, Connecticut
Objectives We sought to examine the relationship between hospital implantable cardioverter-defibrillator (ICD) implantation
volume and procedural complications in a contemporary, representative population.
Background Hospitals that perform higher volumes of procedures generally have better clinical outcomes.
Methods We examined initial ICD implantations between January 2006 and December 2008 at hospitals participating in
the NCDR (National Cardiovascular Data Registry) ICD Registry and evaluated the relationship between hospital
annual implant volume and in-hospital adverse outcomes.
Results The rate of adverse events declined progressively with increasing procedure volume (p trend  0.0001). This relation-
ship remained significant (p trend  0.0001) after adjustment for patient clinical characteristics, operator characteris-
tics, and hospital characteristics. The volume–outcome relationship was evident for all ICD subtypes, including single-
chamber (p trend  0.004), dual-chamber (p trend  0.0001), and biventricular ICDs (p trend  0.02).
Conclusions Patients who have an ICD implanted at a high-volume hospital are less likely to have an adverse event associ-
ated with the procedure than patients who have an ICD implanted at a low-volume hospital. (J Am Coll Cardiol
2010;56:1133–9) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.07.007c
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Iospitals and physicians that perform higher volumes of
rocedures generally have better clinical outcomes (1–6). A
ignificant “volume–outcome” relationship has been dem-
nstrated repeatedly for coronary revascularization proce-
ures (1,2,7–13), but the potential for a similar relationship
ith other cardiac procedures has not been as well
ocumented. A few studies suggest that outcomes are better
hen pacemakers are implanted by high-volume physicians
14–18), but less is known about the relationship between
atient outcomes and procedure volume for implantable
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ccepted July 6, 2010.ardioverter-defibrillator (ICD) procedures (19). Hlatky et
l. (20) found in Medicare data that procedural mortality for
CD implantation fell significantly from 1987 to 1995 and
hat there was a clear “learning curve” for this procedure.
l-Khatib et al. (21) analyzed Medicare data from 1999
hrough 2001 and showed that mechanical complications
nd infections within 90 days of ICD implantations were
nversely related to a hospital’s procedure volume.
Because ICD implantation requires the acquisition and
aintenance of high-level skills, we hypothesized that those
ospitals that perform more procedures should have better
utcomes. This question has not been addressed with more
ecent experience with ICDs or in younger, non-Medicare
atients. Moreover, no previous analysis has evaluated the full
ange of possible in-hospital adverse outcomes or the impor-
ance of the type of ICD implanted on the volume–outcome
elationship. We therefore analyzed the experience of the ICD
egistry to examine the relationship between hospital annual
CD implantation volume and in-hospital procedural compli-
ations in a large contemporary cohort population.
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ICD Implantation Volume Outcome Relationship September 28, 2010:1133–9Methods
The ICD Registry was initiated
in 2005. Hospitals are required
to submit data on ICD implan-
tations for primary prevention
among Medicare patients, and
80% of hospitals submit data on all
ICD implantations performed, ir-
respective of the payer or clinical
indication. As described in detail
elsewhere (22–24), clinical, demo-
graphic, and procedural data are
ecorded in a standardized format based on established data
efinitions, and the quality of submitted data is monitored.
ata on any in-hospital adverse events related to the procedure
re recorded in the ICD registry; long-term follow-up data are
ot available.
For the purposes of this study, we examined all patients
ho had an ICD implanted between January 2006 and
aseline Characteristics Stratified by Quartiles of Hospital AnnualTable 1 Baseline Characteristics Stratified by Quartiles of Hosp
Overall
(n  224,233)
Q1: <
(n  5,6
Patient demographic data
Age, yrs, mean 66.8 66.4
Sex, female 27.0 26.4
Nonwhite race 18.7 19.7
Hispanic ethnicity 5.2 8.3
Insurance payer
Government, Medicare 61.9 57.7
Government, Medicaid 5.3 7.6
Commercial 20.4 20.8
Health Maintenance Organization 7.8 8.0
Patient history and risk factors
Syncope 20.1 21.1
Congestive heart failure 76.4 75.2
Current NYHA functional class
I 13.1 13.8
II 36.2 37.5
III 46.4 42.7
IV 4.3 6.0
Atrial fibrillation/atrial flutter 30.7 28.6
Ventricular tachycardia 35.4 36.3
Sinus node function, abnormal 25.7 23.6
Nonischemic dilated cardiomyopathy 32.4 34.7
Ischemic heart disease 64.5 62.3
Previous myocardial infarction 52.8 51.2
Previous CABG 33.1 31.7
Previous PCI 32.6 28.7
Previous valvular surgery 7.2 6.4
Pacemaker insertion 10.5 8.6
Cerebrovascular disease 14.3 13.3
Chronic lung disease 22.7 22.2
Diabetes 36.7 36.0
Hypertension 74.9 72.5
Abbreviations
and Acronyms
CI  confidence interval
EP  electrophysiology
ICD  implantable
cardioverter-defibrillator
OR  odds ratio
PCI  percutaneous
intervention
Q  quartileecember 2008 at a participating hospital whose data met
he data quality standards established by the NCDR (Na-
ional Cardiovascular Data Registry) (24). Hospitals must
chieve 95% completeness of specific data elements iden-
ified as “core fields” to be included in the registry’s data
arehouse for analysis. In addition, there is a site auditing
rogram that consists of annual on-site chart review and
ata abstraction for at least 5% of participating sites. For a
iven reporting period (quarter), we included ICD implan-
ations that were performed at a hospital that reported all
CD implantations for that reporting period, irrespective of
ayer or indication. We excluded patients who had a
revious ICD or who required epicardial lead placement.
he primary outcome for this study was any adverse event
hat occurred during the implantation or before hospital
ischarge. Major adverse events included cardiac arrest,
ardiac perforation, valve injury, coronary venous dissection,
emothorax, pneumothorax, deep vein thrombosis, tran-
ient ischemic attack, stroke, myocardial infarction, pericar-
olumeAnnual ICD Volume
artile of Hospital Annual ICD Volume (Patients/Yr)
p Value
Q2: 25–56
(n  23,911)
Q3: 57–109
(n  54,724)
Q4: >110
(n  139,940)
67.1 67.2 66.6 0.0001
26.6 26.9 27.1 0.37
18.9 18.0 18.8 0.0001
6.5 6.6 4.4 0.0001
0.0001
63.8 62.1 61.7
5.7 5.8 5.0
19.3 19.2 21.1
6.6 8.3 7.8
20.3 20.1 20.0 0.20
76.8 75.4 76.8 0.0001
0.0001
11.5 13.0 13.3
35.0 34.8 36.9
48.0 47.3 45.9
5.6 4.9 3.8
29.6 30.1 31.2 0.0001
35.2 35.7 35.2 0.22
26.4 26.5 25.4 0.0001
32.9 31.7 32.5 0.0001
64.1 65.1 64.4 0.0001
52.8 52.2 53.1 0.0001
33.7 33.2 33.1 0.04
33.4 32.6 32.6 0.0001
6.2 6.8 7.5 0.0001
10.1 10.1 10.8 0.0001
14.1 14.2 14.4 0.09
23.9 22.6 22.5 0.0001
36.9 36.5 36.8 0.39
75.7 73.9 75.3 0.0001ICD Vital
Qu
24
58)
Renal failure-dialysis 4.0 4.7 4.6 4.3 3.8 0.0001(continued on next page)
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September 28, 2010:1133–9 ICD Implantation Volume Outcome Relationshipial tamponade, and arteriovenous fistula. Any adverse
vent included these major adverse events as well as drug
eactions, conduction block, hematoma, lead dislodgement,
eripheral embolus, superficial phlebitis, peripheral nerve
njury, and device-related infection.
We determined hospital annual volume by dividing the
otal number of ICD implantations by the number of
uarters the hospital contributed data and multiplying by 4.
e ranked hospitals by annual ICD implantation volume
nd divided them into quartiles of increasing procedure
olume for descriptive analysis.
tatistical methods. We evaluated the baseline patient
linical characteristics, implanting physician certification,
ontinuedTable 1 Continued
Overall
(n  224,233)
Q1: <
(n  5,6
Patient diagnostic and ICD data
Ejection fraction, mean 27.8 27.4
EP study done 14.7 5.6
QRS duration categories, ms
120 51.0 55.3
120 and 140 16.2 16.1
140 32.8 28.6
Intraventricular conduction delay or paced 53.8 50.6
Left bundle branch block 29.5 27.8
Creatinine level, mean 1.37 1.3
BUN level, mean 23.8 23.9
Sodium level, mean 138.5 138.2
Systolic blood pressure, mean 130.0 128.1
ICD indication: primary prevention 80.7 78.4
ICD type
Missing 0.15 0.0
Single-chamber 24.8 32.1
Dual-chamber 41.8 45.0
Biventricular 33.2 22.9
Implanting physician certification
Physician certification
EP board-certified 76.1 48.9
EP fellowship only 6.2 4.3
Surgery board-certified 1.7 5.7
Pediatric cardiology board-certified 0.1 0
HRS guideline trained 9.8 30.5
None of the above 6.2 10.6
Hospital characteristics
Hospital type
Government 1.4 3.8
Private/community 85.8 94.5
University 12.8 1.7
Community hospital geographic type
Rural 10.0 32.5
Suburban 27.4 30.6
Urban 62.6 36.8
Patient beds, mean 481.0 236.3
Teaching hospital 54.1 24.1UN  blood urea nitrogen; CABG  coronary artery bypass graft surgery; EP  electrophysiology; ICD
CI  percutaneous intervention; Q1  first quartile; Q2  second quartile; Q3  third quartile; Q4  fond hospital characteristics among hospitals in different
uartiles of annual procedure volume with analysis of
ariance for continuous variables and the chi-square test for
ategorical variables. In the primary analysis, we used
ierarchical logistic regression to test for a declining rate
f any adverse event according to quartiles of increasing
ospital annual ICD volume, unadjusted for other charac-
eristics, and the Cochran-Armitage trend test was used to
enerate the p-trend. We repeated the analysis after sequen-
ially adjusting for patient clinical characteristics, then
hysician certification (electrophysiology [EP] board certi-
ed, EP fellowship, surgery boards, pediatric cardiology
oards, Heart Rhythm Society guidelines, none) in addition
artile of Hospital Annual ICD Volume (Patients/Yr)
p Value
Q2: 25–56
(n  23,911)
Q3: 57–109
(n  54,724)
Q4: >110
(n  139,940)
27.4 27.9 27.8 0.0001
9.5 13.3 16.5 0.0001
0.0001
51.3 50.5 51.0
16.6 16.5 16.1
32.1 33.0 33.0
53.8 54.8 53.4 0.0001
29.6 30.3 29.2
1.39 1.37 1.36 0.001
23.7 24.0 23.8 0.02
138.3 138.4 138.6 0.0001
129.5 128.9 130.6 0.0001
80.5 81.1 80.6 0.0001
0.0001
0.08 0.16 0.16
23.9 25.0 24.6
44.4 41.8 41.3
31.6 33.1 34.0
0.0001
57.9 73.4 81.4
4.9 6.1 6.5
4.6 1.7 1.1
0.3 0 0.1
22.6 10.1 6.6
9.7 8.8 4.3
0.0001
2.2 1.7 1.1
93.0 89.0 82.9
4.8 9.4 16.0
0.0001
21.0 11.4 6.6
37.6 33.0 23.3
41.4 55.5 70.1
293.5 382.5 561.5 0.0001
30.2 45.9 62.6 0.0001Qu
24
58)
9
5 implantable cardioverter-defibrillator; NYHA  New York Heart Association functional class;
urth quartile.
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ICD Implantation Volume Outcome Relationship September 28, 2010:1133–9o patient characteristics, and finally, hospital characteristics
number of beds, teaching status, urban location) in addi-
ion to patient and physician characteristics. In a secondary
nalysis, we tested for a declining rate of adverse events
ssociated with implantation of each of the ICD subtypes
single-chamber, dual-chamber, and biventricular) accord-
ng to increasing hospital annual ICD volume. We con-
ucted this secondary analysis first with overall hospital
nnual ICD volume and second with hospital annual
olume for each subtype of ICD.
esults
here were 333,993 patients who underwent an ICD
mplantation between January 2006 and December 2008 at
of 1,356 hospitals participating in the ICD Registry. After
xclusion of 31,527 patients treated at 1 of the 147 hospitals
hat did not report all ICD implantations for a given
eporting period, 5,310 patients who had epicardial leads
mplanted, and 72,923 patients who had previously under-
one ICD implantation, the study population consisted of
24,233 patients from 1,201 hospitals. The median length
f stay was 1 day (interquartile range 1 to 6 days).
Hospital annual ICD procedure volume varied widely,
ith a median of 57 patients/year (interquartile range 24 to
09 patients/year). The 125 hospitals in the lowest decile of
ospital annual ICD volume performed a median of 8
mplants/year, whereas the 120 hospitals in the highest
ecile of hospital annual ICD volume performed a median
f 248 implants/year. Clinical characteristics of patients
aried somewhat by hospital annual ICD procedure volume
Table 1). Most differences were small in absolute terms
2%), yet were statistically significant because of the large
ample size in the study. More of the ICD implantations at
he higher-volume hospitals were performed by board cer-
ate of Adverse Events, Stratified by Quartiles of Hospital Annual ITable 2 Rate of Adverse Events, Stratified by Quartiles of Hosp
Adverse Event Type Overall
Q
Q1: <24
All ICD types
Any complications (n  7,151) 3.19 3.82
Major complications (n  2,701) 1.20 1.56
In-hospital death (n  919) 0.41 0.60
Single-chamber ICD
Any complications (n  1,103) 1.98 3.14
Major complications (n  439) 0.79 1.32
In-hospital death (n  159) 0.29 0.72
Dual-chamber ICD
Any complications (n  2,816) 3.00 3.97
Major complications (n  1,123) 1.20 1.73
In-hospital death (n  373) 0.40 0.59
Biventricular ICD
Any complications (n  3,223) 4.32 4.48
Major complications (n  1,136) 1.52 1.54
In-hospital death (n  386) 0.52 0.46er 100 patients.
Abbreviations as in Table 1.ified cardiac EP physicians or by fellows training in cardiac
P. In addition, higher-volume hospitals were more likely
o be teaching hospitals and academic centers and were
ore likely to be located in urban areas.
Overall, 7,151 patients (3.2%) had an adverse event after
CD implantation, 2,701 (1.2%) of whom experienced a
ajor adverse event (Table 2). The rate of adverse events
as lower among patients who received a single-chamber
CD (2.0%) than among patients who received a dual-
hamber ICD (3.0%) or a biventricular ICD (4.3%). The
ost common adverse events were lead dislodgement
1.0%), hematoma (0.9%), pneumothorax (0.5%), and car-
iac arrest (0.3%); this pattern was consistent across quartiles of
ospital annual ICD volume and types of ICD placed.
The rate of any adverse event declined significantly
p trend  0.0001) with increasing hospital annual proce-
ure volume (Table 2, Fig. 1). The inverse relationship
etween hospital ICD volume and clinical outcomes re-
ained significant when the analysis was restricted to major
dverse events (Table 2). The inverse relationship between
ospital annual procedure volume and in-hospital death was
ot significant among all ICD types, but was significant
mong single-chamber ICDs (p trend  0.03) (Table 2).
he overall inverse relationship between hospital annual
CD volume and any adverse event remained statistically
ignificant after adjustment for patient clinical characteris-
ics, operator characteristics, and hospital characteristics
Table 3).
The adjusted odds of any adverse event after ICD
mplantation were significantly higher in the lowest-volume
uartile compared with the highest-volume quartile (odds
atio [OR]: 1.26, 95% confidence interval [CI]: 1.05 to
.52) (Table 3). This relationship was statistically strongest
or single-chamber ICDs (OR: 1.69, 95% CI: 1.22 to 2.35)
olumennual ICD Volume
of Hospital Annual ICD Volume, Patients/Yr
p TrendQ2: 25–56 Q3: 57–109 Q4: >110
3.58 3.22 3.08 0.0001
1.45 1.27 1.12 0.0001
0.42 0.41 0.40 0.12
2.07 2.02 1.90 0.004
0.88 0.85 0.72 0.005
0.30 0.27 0.27 0.03
3.32 3.14 2.85 0.0001
1.30 1.28 1.12 0.002
0.41 0.44 0.37 0.07
5.05 4.23 4.24 0.02
2.09 1.57 1.42 0.0002
0.53 0.46 0.54 0.48CD Vital A
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September 28, 2010:1133–9 ICD Implantation Volume Outcome Relationshipnd dual-chamber ICDs (OR: 1.32, 95% CI: 1.03 to 1.68)
Table 4). For biventricular ICDs the adjusted OR for the
owest quartile compared with the highest quartile was not
tatistically significant (OR: 0.99, 95% CI: 0.73 to 1.37), but
he inverse trend relationship between hospital annual ICD
olume and outcome was significant when tested over all 4
uartiles of volume (p trend  0.02) (Table 4).
To further investigate whether the volume–outcome
elationship for biventricular ICDs meaningfully differed
rom the other ICD subtypes, we evaluated the correlation
etween the subgroups and the overall group. We demon-
trated strong correlation between hospital annual volume of
ll ICDs and hospital annual volume of biventricular ICDs,
ith a correlation coefficient of 0.93. In a fully adjusted
egression analysis, the interaction between ICD subtype
nd hospital annual ICD volume was not statistically
Figure 1 Unadjusted Rate of Any Complication
by Hospital Annual ICD Procedure Volume
Unadjusted rate of any complication (vertical axis) by hospital annual implant-
able cardioverter-defibrillator (ICD) procedure volume (horizontal axis). Each
point represents a single hospital (n  1,201), and the solid line indicates the
locally smoothed relationship between hospital annual ICD volume and any
complication. The unadjusted rate of any complication decreases steadily with
increasing hospital annual ICD procedure volume.
dds Ratios of Any Complication Comparing the Lowest 3 Quartilef Hospi al Annual I D Volume With the Hi hest V lume QuartileTable 3 Odds Ratios of Any Complicat on Comparing the Lowof Hospital Annual ICD Volume With the Highest Volum
Quartile of Hospital
Q1: <24
Unadjusted 1.26 (1.06–1.49) 1.
Adjusted for “1” 1.27 (1.07–1.50) 1.
Adjusted for “2” 1.26 (1.06–1.48) 1.
Adjusted for “3” 1.32 (1.12–1.56) 1.
Adjusted for “4” 1.23 (1.04–1.46) 1.
Adjusted for “5” 1.26 (1.05–1.52) 1.
eference is fourth quartile (110). 1: Demographic data (age, sex, race, and payer status). 2: 1
ardiac arrest, atrial fibrillation/atrial flutter, ventricular tachycardia, nonischemic dilated cardio
alvular surgery, cerebrovascular disease, chronic lung disease, diabetes, hypertension, and renal fa
itrogen, and ICD type). 4: 3 implanting physician certification (electrophysiology board certified, s
ospital characteristics (geographic location, profit type, community, patient beds, and teaching status).
Abbreviations as in Table 1.ignificant (p 0.39), excluding a strong effect modification
f the volume–outcome relationship by ICD subtype.
iscussion
his study demonstrates an inverse relationship between the
ate of procedure-related adverse events and the annual
olume of ICDs implanted at a hospital. This inverse
olume–outcome relationship was statistically significant
or all ICDs and for each of the ICD subtypes. The lowest
nnual volume quartile of hospitals in this study had 26%
igher odds of any adverse event than the highest annual
olume quartile of hospitals. This effect of procedure vol-
me on outcomes confirms the findings of Al-Khatib et al.
21) in their study of mechanical complications and infec-
ions after ICD implantation in Medicare beneficiaries. Our
tudy extends these findings by including patients of all
ges, including a broader array of adverse events, and
xamining the type of ICD implanted.
A strength of our analysis is the availability of detailed
aseline data on patient characteristics, operator character-
stics, and hospital characteristics. The inverse volume–
utcome relationship was unaffected by systematic adjust-
ent for these baseline characteristics. The patients enrolled
t higher annual volume centers had more adverse clinical
haracteristics, but there was little evidence that referral bias
ed to the volume–outcome relationship we observed. There
ere very significant differences in implanting operator
haracteristics; at the highest annual volume hospitals the
mplanters were markedly more likely to be board certified
r board eligible in EP. However, the inverse relationship
etween hospital annual volume and outcome remained
ignificant after adjusting for physician characteristics. Fi-
ally, the highest annual volume centers were significantly
ore likely to be teaching hospitals, academic centers, and
eographically urban, but again adjustment for these factors
id not affect the magnitude of the volume–outcome
elationship. Thus, the most likely explanation of our
ndings is that high-volume hospitals are more likely to
ave better outcomes as a result of their greater experience.
uartiles
artile
l ICD Volume (Patients/Yr)
p Trend5–56 Q3: 57–109
4–1.31) 1.04 (0.94–1.15) 0.0001
4–1.30) 1.03 (0.93–1.14) 0.0001
2–1.28) 1.02 (0.92–1.13) 0.0001
3–1.30) 1.03 (0.93–1.14) 0.0001
8–1.24) 1.02 (0.92–1.12) 0.0001
9–1.29) 1.03 (0.93–1.15) 0.0001
nt history and risk factors (congestive heart failure, New York Heart Association functional class,
hy, ischemic heart disease, previous myocardial infarction, previous revascularization, previous
quiring dialysis). 3: 2 diagnostic data (left ventricular ejection fraction, QRS duration, blood urea
boards, pediatric cardiology boards, Heart Rhythm Society guidelines, or none of the above). 5: 4st 3 Q
e Qu
Annua
Q2: 2
17 (1.0
16 (1.0
14 (1.0
16 (1.0
10 (0.9
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ICD Implantation Volume Outcome Relationship September 28, 2010:1133–9We demonstrated a consistent volume–outcome relation-
hip for all of the ICD subtypes (interaction p value 
.39), but the relationship was not as strong for biventricular
CDs. The confidence limits for the OR for any adverse
vent comparing the lowest-volume quartile with the
ighest-volume quartile for biventricular devices included
.0, even though the overall trend between volume and
utcome was significant (p trend  0.02). There are
ultiple possible mechanisms that could explain a weaker
olume–outcome relationship for biventricular ICDs. The
atients undergoing biventricular ICD implantation were
arkedly older (mean age 70 years vs. 63 years for single-
hamber) and more ill (86% with New York Heart Associ-
tion functional class III/IV vs. 32% for single-chamber),
nd the increased risk of adverse events due to poorer overall
ealth status might have overwhelmed any advantage con-
erred by higher implanting volume. In addition, it is
ossible that only more-skilled operators attempted the
ore-complicated biventricular ICD implantations. This
hysician self-selection would minimize the variation in
utcomes associated with the less-complicated device im-
lantations. Future investigation is needed to further eval-
ate these hypotheses.
tudy limitations. First, we only included procedures per-
ormed between 2006 and 2008. Consequently, we were
nable to assess the overall long-term experience of centers
ith ICD implantation. Second, the hospital annual volume
f ICD implantations might not have been uniform over the
years of the study, and our analysis did not account for this
ossible variation. Third, we only had data on in-hospital
dverse events and were unable to assess the impact of
ospital procedure volume on long-term adverse events.
ourth, we only included hospitals whose data met the data
uality standards of the NCDR, which might have biased
ur results. Finally, we did not evaluate the effect of
ndividual physician implantation volume on the rate of
dverse events. Hospital volume and physician volume
ight have independent effects on adverse event rates as
ell as effect interaction, and these complicated relation-
hips will need to be evaluated in future studies.
onclusions
ur findings demonstrate that patients who have an ICD
ully Adjusted ORs of Any Complication Comparing the Lowest 3 Qospital Annual ICD Volume With the Highest Volume Quartile as tTable 4 Fully Adjusted ORs of Any Complication Comparing theHospital Annual ICD Volume With the Highest Volume
ICD Type Complications Q1: <24
All ICD (n  224,233) 7,151 (3.2%) 1.26 (1.05–1.52
Single-chamber (n  55,606) 1,103 (2.0%) 1.69 (1.22–2.35
Dual-chamber (n  93,768) 2,816 (3.0%) 1.32 (1.03–1.68
Biventricular (n  74,528) 3,223 (4.3%) 0.99 (0.73–1.37
alues are n (rate) or adjusted odds ratio (95% confidence interval). *Reference is fourth quartile
Abbreviations as in Table 1.mplanted at a high volume hospital are less likely to have andverse event associated with the procedure than a patient
ho has an ICD implanted at a low-volume center. This
olume–outcome relationship was statistically significant,
linically important, and consistent across all subtypes of
CDs, suggesting that implantation of these devices might
e preferentially performed at high-volume centers.
eprint requests and correspondence: Dr. James V. Freeman,
tanford University School of Medicine, 300 Pasteur Drive, Falk
uilding, CVRC 5406, Stanford, California 94305-5406. E-mail:
freeman@stanford.edu.
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